Luciano Stürmer de Fraga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Luciano Stürmer de Fraga has a total of 143 co-authors. Here are the top co-authors by number of shared publications:
- Isadora Tassinari
Laboratory of Neurobiology and Metabolism (NeuroMet), Department of Physiology, Institute for Basic Health Sciences, Federal University of Rio Grande do Sul, Porto Alegre 90035-003, Brazil
7 shared publications Carlos Alexandre Netto
Post-graduation Program in Biochemistry, Department of Biochemistry, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
5 shared publications- Renata Padilha Guedes
Graduate Program in Biosciences, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, Brazil
5 shared publications Ana Helena Paz
Univ Fed Rio Grande do Sul UFRGS, Programa Posgrad Grad Ciencias Biol Fisiol, Inst Ciencias Bas Saude ICBS, Porto Alegre, Brazil
4 shared publicationsRicardo Ribeiro Nunes
Univ Fed Rio Grande do Sul UFRGS, Programa Posgrad Grad Ciencias Biol Fisiol, Inst Ciencias Bas Saude ICBS, Porto Alegre, Brazil
4 shared publications- Ana Helena Paz
Hospital de Clínicas de Porto Alegre
3 shared publications
Latest Publications
- Open Access
- 29 August 2026
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 41 (1) , 194
Sex-specific effects of therapeutic hypothermia on short- and long-term microglial and astrocytic reactivity after severe neonatal hypoxia–ischemia
Therapeutic hypothermia (TH) is the standard treatment to reduce mortality and neurological impairments after neonatal hypoxia–ischemia (HI). However, TH does not fully suppress neuroinflammation, leading to persistent neuroinflammatory responses that may exacerbate brain injury and limit TH efficacy. In addition, the influence of sexual dimorphism on these outcomes remains poorly understood. We investigated short- and long-term microglial and astrocytic reactivity in male and female neonatal rats following HI and TH treatment. At postnatal day 7 (PND7), male and female pups underwent right common carotid occlusion followed by exposure to hypoxia (8% O2). TH was induced by reducing body temperature to 32°C for 5 h. Brains were collected at PND8 or PND21 to assess brain injury volume, brain water content, and microglial and astrocytic reactivity based on Iba-1 and GFAP mean fluorescence intensity. Behavioral impairments were evaluated using negative geotaxis, olfactory discrimination, and cylinder tests. TH did not reduce injury volume but attenuated neuronal cell loss in males and reduced brain edema in females. In males, microglial reactivity was reduced by TH at PND8 and PND21 and astrocytic reactivity only at PND8. Olfactory discrimination was impaired in females and prevented by TH, whereas motor performance deficits and developmental impairments were not prevented by TH. Our results reinforce that the neuroprotective efficacy of TH is limited in severe HI injury and that, despite reducing early neuroinflammation, TH fails to prevent long-term neuroinflammatory responses. Notably, the early anti-inflammatory effects were only observed in males, underscoring the need for additional therapeutic strategies, particularly for females. Graphical Abstract
- 29 August 2026
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 41 (1) , 194
Open AccessSex-specific effects of therapeutic hypothermia on short- and long-term microglial and astrocytic reactivity after severe neonatal hypoxia–ischemia
Therapeutic hypothermia (TH) is the standard treatment to reduce mortality and neurological impairments after neonatal hypoxia–ischemia (HI). However, TH does not fully suppress neuroinflammation, leading to persistent neuroinflammatory responses that may exacerbate brain injury and limit TH efficacy. In addition, the influence of sexual dimorphism on these outcomes remains poorly understood. We investigated short- and long-term microglial and astrocytic reactivity in male and female neonatal rats following HI and TH treatment. At postnatal day 7 (PND7), male and female pups underwent right common carotid occlusion followed by exposure to hypoxia (8% O2). TH was induced by reducing body temperature to 32°C for 5 h. Brains were collected at PND8 or PND21 to assess brain injury volume, brain water content, and microglial and astrocytic reactivity based on Iba-1 and GFAP mean fluorescence intensity. Behavioral impairments were evaluated using negative geotaxis, olfactory discrimination, and cylinder tests. TH did not reduce injury volume but attenuated neuronal cell loss in males and reduced brain edema in females. In males, microglial reactivity was reduced by TH at PND8 and PND21 and astrocytic reactivity only at PND8. Olfactory discrimination was impaired in females and prevented by TH, whereas motor performance deficits and developmental impairments were not prevented by TH. Our results reinforce that the neuroprotective efficacy of TH is limited in severe HI injury and that, despite reducing early neuroinflammation, TH fails to prevent long-term neuroinflammatory responses. Notably, the early anti-inflammatory effects were only observed in males, underscoring the need for additional therapeutic strategies, particularly for females. Graphical Abstract
- Open Access
- 30 June 2026
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (11) , 1-17
Effects of cannabidiol on anxiety- and depressive-like behaviors and cognition: a systematic review and meta-analysis of preclinical studies
Background: Cannabidiol (CBD) has emerged as a promising neuroprotective compound, with potential benefits for cognitive and emotional behaviors. However, the consistency of its effects across preclinical models remains uncertain. Methods: We conducted a systematic review and meta-analysis of 123 animal studies assessing the impact of CBD on anxiety-like and depressive-like behaviors, as well as cognition. Results: CBD consistently reduced anxiety- and depressive-like behaviors, with moderate effect sizes observed in paradigms such as the elevated plus maze, novelty suppressed feeding, forced swim, sucrose preference, and tail suspension test. Cognitive effects were more heterogeneous: CBD improved performance in adverse, discriminatory, and working memory tasks, while effects were small or inconsistent in hippocampus-dependent spatial memory tests. Subgroup analyses revealed that CBD’s efficacy often depended on the type of behavioral test and the presence of underlying pathologies. Mechanistic evidence implicates serotonergic signaling (notably 5-HT1A receptors), endocannabinoid modulation, anti-inflammatory and neurotrophic pathways, as well as mitochondrial and synaptic plasticity processes, as contributors to these behavioral outcomes. Risk of bias assessment indicated moderate to high quality across studies, confirming the robustness of the findings. Conclusions: Overall, our results indicate that CBD reduces anxiety-like and depressive-like behaviors and improves cognitive performance across a variety of preclinical models. While these findings support its therapeutic potential and provide a rationale for guiding translational research, clinical evidence in humans is still limited and inconclusive, underscoring the need for further research.
- 30 June 2026
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (11) , 1-17
Open AccessEffects of cannabidiol on anxiety- and depressive-like behaviors and cognition: a systematic review and meta-analysis of preclinical studies
Background: Cannabidiol (CBD) has emerged as a promising neuroprotective compound, with potential benefits for cognitive and emotional behaviors. However, the consistency of its effects across preclinical models remains uncertain. Methods: We conducted a systematic review and meta-analysis of 123 animal studies assessing the impact of CBD on anxiety-like and depressive-like behaviors, as well as cognition. Results: CBD consistently reduced anxiety- and depressive-like behaviors, with moderate effect sizes observed in paradigms such as the elevated plus maze, novelty suppressed feeding, forced swim, sucrose preference, and tail suspension test. Cognitive effects were more heterogeneous: CBD improved performance in adverse, discriminatory, and working memory tasks, while effects were small or inconsistent in hippocampus-dependent spatial memory tests. Subgroup analyses revealed that CBD’s efficacy often depended on the type of behavioral test and the presence of underlying pathologies. Mechanistic evidence implicates serotonergic signaling (notably 5-HT1A receptors), endocannabinoid modulation, anti-inflammatory and neurotrophic pathways, as well as mitochondrial and synaptic plasticity processes, as contributors to these behavioral outcomes. Risk of bias assessment indicated moderate to high quality across studies, confirming the robustness of the findings. Conclusions: Overall, our results indicate that CBD reduces anxiety-like and depressive-like behaviors and improves cognitive performance across a variety of preclinical models. While these findings support its therapeutic potential and provide a rationale for guiding translational research, clinical evidence in humans is still limited and inconclusive, underscoring the need for further research.
- Open Access
- 1 January 2026
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 14, 163959-163978
Network-Wide Association Optimization With Learned Mobility Prediction for Minimizing Breaks in Presence in Mobile Augmented Reality
- 1 January 2026
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 14, 163959-163978
Open AccessNetwork-Wide Association Optimization With Learned Mobility Prediction for Minimizing Breaks in Presence in Mobile Augmented Reality
- 7 October 2025
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 40 (7) , 1-12
Differential effects of hypothermia and memantine in neonatal hypoxia-ischemia
Therapeutic hypothermia (TH) is the standard treatment for neonatal hypoxia-ischemia (HI), but its efficacy is limited. Understanding the molecular pathways involved in cell death and survival, while considering sex-related differences, is essential to optimize therapeutic strategies. This study evaluated the neuroprotective effects of memantine, a non-competitive NMDA receptor antagonist, alone or in combination with TH, in male and female neonatal rats subjected to HI. Seven-day-old pups (P7) underwent right common carotid artery occlusion followed by 90 min of hypoxia (8% O2). Memantine (20 mg/kg, i.p.) was administered immediately after hypoxia, followed by TH (32 °C for 5 h). Neurobehavioral tests were performed at P8, and animals were euthanized at P9 for assessment of brain injury and analysis of cleaved caspase-3, p-Akt, Bcl-2, and Bax levels by Western blot. The results showed that the treatments reversed the deficits in the righting reflex in females, but not in males. Memantine and TH - combined or alone - reduced infarct volume in males, while in females, memantine alone exerted a neuroprotective effect. Cleaved caspase-3 levels were reduced in both sexes in groups treated with memantine; in females, this reduction was also observed following TH alone or in combination with memantine. In males, both memantine and TH - either combined or alone - increased the Bcl-2/Bax ratio. In females, only the individual treatments (memantine or TH alone) promoted this anti-apoptotic effect. These findings highlight a sex-dependent differential effect of memantine and TH on neuroprotection.
- 7 October 2025
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 40 (7) , 1-12
Differential effects of hypothermia and memantine in neonatal hypoxia-ischemia
Therapeutic hypothermia (TH) is the standard treatment for neonatal hypoxia-ischemia (HI), but its efficacy is limited. Understanding the molecular pathways involved in cell death and survival, while considering sex-related differences, is essential to optimize therapeutic strategies. This study evaluated the neuroprotective effects of memantine, a non-competitive NMDA receptor antagonist, alone or in combination with TH, in male and female neonatal rats subjected to HI. Seven-day-old pups (P7) underwent right common carotid artery occlusion followed by 90 min of hypoxia (8% O2). Memantine (20 mg/kg, i.p.) was administered immediately after hypoxia, followed by TH (32 °C for 5 h). Neurobehavioral tests were performed at P8, and animals were euthanized at P9 for assessment of brain injury and analysis of cleaved caspase-3, p-Akt, Bcl-2, and Bax levels by Western blot. The results showed that the treatments reversed the deficits in the righting reflex in females, but not in males. Memantine and TH - combined or alone - reduced infarct volume in males, while in females, memantine alone exerted a neuroprotective effect. Cleaved caspase-3 levels were reduced in both sexes in groups treated with memantine; in females, this reduction was also observed following TH alone or in combination with memantine. In males, both memantine and TH - either combined or alone - increased the Bcl-2/Bax ratio. In females, only the individual treatments (memantine or TH alone) promoted this anti-apoptotic effect. These findings highlight a sex-dependent differential effect of memantine and TH on neuroprotection.
- 25 June 2025
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 45 (11) , 2217-2232
Combined effects of β -hydroxybutyrate and therapeutic hypothermia in a neonatal hypoxia-ischemia model
Hypoxia-ischemia (HI) is one of the leading causes of brain damage during the development of newborns. It can result in death or cause varying degrees of neurological disability. The only well-established treatment currently available for neonatal HI is therapeutic hypothermia (TH). However, TH is only partially protective, reducing severe disability by approximately 11%. Therefore, new therapeutic approaches are urgently needed. It is known that immature brains utilize higher levels of ketone bodies, such as β-hydroxybutyrate (BHB), that may contribute to resistance to hypoxic-ischemic events. In this study, 11-day-old animals were subjected to the neonatal HI (Rice-Vannucci model) and treated with TH alone or in combination with BHB administration. To assess brain metabolism, glucose uptake was evaluated using MicroPET at 72 hours post-injury and when the animals reached 65 days of age. Behavioral tests, brain volume analysis, hippocampal cell counting and the assessment of hippocampal inflammatory cytokines expression were also performed. Animals treated with BHB exhibited increased glucose uptake at 72 hours post-injury and a reduction in neuronal loss in the hippocampus. The combined use of BHB and TH resulted in enhanced hippocampal neuronal survival, suggesting that BHB may represent a promising future treatment for neonatal HI.
- 25 June 2025
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 45 (11) , 2217-2232
Combined effects of β -hydroxybutyrate and therapeutic hypothermia in a neonatal hypoxia-ischemia model
Hypoxia-ischemia (HI) is one of the leading causes of brain damage during the development of newborns. It can result in death or cause varying degrees of neurological disability. The only well-established treatment currently available for neonatal HI is therapeutic hypothermia (TH). However, TH is only partially protective, reducing severe disability by approximately 11%. Therefore, new therapeutic approaches are urgently needed. It is known that immature brains utilize higher levels of ketone bodies, such as β-hydroxybutyrate (BHB), that may contribute to resistance to hypoxic-ischemic events. In this study, 11-day-old animals were subjected to the neonatal HI (Rice-Vannucci model) and treated with TH alone or in combination with BHB administration. To assess brain metabolism, glucose uptake was evaluated using MicroPET at 72 hours post-injury and when the animals reached 65 days of age. Behavioral tests, brain volume analysis, hippocampal cell counting and the assessment of hippocampal inflammatory cytokines expression were also performed. Animals treated with BHB exhibited increased glucose uptake at 72 hours post-injury and a reduction in neuronal loss in the hippocampus. The combined use of BHB and TH resulted in enhanced hippocampal neuronal survival, suggesting that BHB may represent a promising future treatment for neonatal HI.
- 5 December 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 145, 113682
Impact of peripheral immune cells in experimental neonatal hypoxia-ischemia: A systematic review and meta-analysis
- 5 December 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 145, 113682
Impact of peripheral immune cells in experimental neonatal hypoxia-ischemia: A systematic review and meta-analysis
- 22 August 2024
- Published by Elsevier in Experimental Neurology
- Vol. 381, 114929
Lactate administration causes long-term neuroprotective effects following neonatal hypoxia-ischemia
- 22 August 2024
- Published by Elsevier in Experimental Neurology
- Vol. 381, 114929
Lactate administration causes long-term neuroprotective effects following neonatal hypoxia-ischemia
- 29 March 2024
- Published by Springer Nature in Neurochemical Research
- Vol. 49 (7) , 1762-1781
Lactate Protects Microglia and Neurons from Oxygen–Glucose Deprivation/Reoxygenation
Lactate has received attention as a potential therapeutic intervention for brain diseases, particularly those including energy deficit, exacerbated inflammation, and disrupted redox status, such as cerebral ischemia. However, lactate roles in metabolic or signaling pathways in neural cells remain elusive in the hypoxic and ischemic contexts. Here, we tested the effects of lactate on the survival of a microglial (BV-2) and a neuronal (SH-SY5Y) cell lines during oxygen and glucose deprivation (OGD) or OGD followed by reoxygenation (OGD/R). Lactate signaling was studied by using 3,5-DHBA, an exogenous agonist of lactate receptor GPR81. Inhibition of lactate dehydrogenase (LDH) or monocarboxylate transporters (MCT), using oxamate or 4-CIN, respectively, was performed to evaluate the impact of lactate metabolization and transport on cell viability. The OGD lasted 6 h and the reoxygenation lasted 24 h following OGD (OGD/R). Cell viability, extracellular lactate concentrations, microglial intracellular pH and TNF-ɑ release, and neurite elongation were evaluated. Lactate or 3,5-DHBA treatment during OGD increased microglial survival during reoxygenation. Inhibition of lactate metabolism and transport impaired microglial and neuronal viability. OGD led to intracellular acidification in BV-2 cells, and reoxygenation increased the release of TNF-ɑ, which was reverted by lactate and 3,5-DHBA treatment. Our results suggest that lactate plays a dual role in OGD, acting as a metabolic and a signaling molecule in BV-2 and SH-SY5Y cells. Lactate metabolism and transport are vital for cell survival during OGD. Moreover, lactate treatment and GPR81 activation during OGD promote long-term adaptations that potentially protect cells against secondary cell death during reoxygenation. Graphical Abstract
- 29 March 2024
- Published by Springer Nature in Neurochemical Research
- Vol. 49 (7) , 1762-1781
Lactate Protects Microglia and Neurons from Oxygen–Glucose Deprivation/Reoxygenation
Lactate has received attention as a potential therapeutic intervention for brain diseases, particularly those including energy deficit, exacerbated inflammation, and disrupted redox status, such as cerebral ischemia. However, lactate roles in metabolic or signaling pathways in neural cells remain elusive in the hypoxic and ischemic contexts. Here, we tested the effects of lactate on the survival of a microglial (BV-2) and a neuronal (SH-SY5Y) cell lines during oxygen and glucose deprivation (OGD) or OGD followed by reoxygenation (OGD/R). Lactate signaling was studied by using 3,5-DHBA, an exogenous agonist of lactate receptor GPR81. Inhibition of lactate dehydrogenase (LDH) or monocarboxylate transporters (MCT), using oxamate or 4-CIN, respectively, was performed to evaluate the impact of lactate metabolization and transport on cell viability. The OGD lasted 6 h and the reoxygenation lasted 24 h following OGD (OGD/R). Cell viability, extracellular lactate concentrations, microglial intracellular pH and TNF-ɑ release, and neurite elongation were evaluated. Lactate or 3,5-DHBA treatment during OGD increased microglial survival during reoxygenation. Inhibition of lactate metabolism and transport impaired microglial and neuronal viability. OGD led to intracellular acidification in BV-2 cells, and reoxygenation increased the release of TNF-ɑ, which was reverted by lactate and 3,5-DHBA treatment. Our results suggest that lactate plays a dual role in OGD, acting as a metabolic and a signaling molecule in BV-2 and SH-SY5Y cells. Lactate metabolism and transport are vital for cell survival during OGD. Moreover, lactate treatment and GPR81 activation during OGD promote long-term adaptations that potentially protect cells against secondary cell death during reoxygenation. Graphical Abstract
- Open Access
- 31 October 2023
- Published by S. Karger AG in Developmental Neuroscience
- Vol. 46 (4) , 273-284
Therapeutic Hypothermia Is Limited in Preventing Developmental Impairments after Neonatal Hypoxia-Ischemia
The only current treatment for neonatal hypoxia-ischemia (HI) is therapeutic hypothermia (TH), which still shows some limitations. Specific effects of TH in the several processes involved in brain injury progression remain unclear. In this study, the effects of TH treatment on developmental parameters, behavioral outcomes, and peripheral leukocytes were evaluated in neonatal male and female rats. In P7, animals were submitted to right common carotid artery occlusion followed by hypoxia (8% oxygen). TH was performed by reducing the animal scalp temperature to 32°C for 5 h. Behavioral parameters and developmental landmarks were evaluated. Animals were euthanized at P9 or P21, and cerebral hemispheres, spleen, and thymus were weighed. White blood cells (WBCs) were counted in blood smears. There was a reduction in the weight of the brain hemisphere ipsilateral to the carotid occlusion in HI and TH groups, as well as a reduction in body weight gain and a delay in the opening of the ipsilateral eye. Latency in negative geotaxis was increased by HI at P12. TH did not prevent brain weight loss, developmental impairments, or WBC number changes but prevented negative geotaxis impairment and spleen weight reduction. These data reinforce that a better understanding of the events that occur after HI and TH in both males and females is necessary and would allow the development of more adequate and sex-specific therapeutic approaches.
- 31 October 2023
- Published by S. Karger AG in Developmental Neuroscience
- Vol. 46 (4) , 273-284
Open AccessTherapeutic Hypothermia Is Limited in Preventing Developmental Impairments after Neonatal Hypoxia-Ischemia
The only current treatment for neonatal hypoxia-ischemia (HI) is therapeutic hypothermia (TH), which still shows some limitations. Specific effects of TH in the several processes involved in brain injury progression remain unclear. In this study, the effects of TH treatment on developmental parameters, behavioral outcomes, and peripheral leukocytes were evaluated in neonatal male and female rats. In P7, animals were submitted to right common carotid artery occlusion followed by hypoxia (8% oxygen). TH was performed by reducing the animal scalp temperature to 32°C for 5 h. Behavioral parameters and developmental landmarks were evaluated. Animals were euthanized at P9 or P21, and cerebral hemispheres, spleen, and thymus were weighed. White blood cells (WBCs) were counted in blood smears. There was a reduction in the weight of the brain hemisphere ipsilateral to the carotid occlusion in HI and TH groups, as well as a reduction in body weight gain and a delay in the opening of the ipsilateral eye. Latency in negative geotaxis was increased by HI at P12. TH did not prevent brain weight loss, developmental impairments, or WBC number changes but prevented negative geotaxis impairment and spleen weight reduction. These data reinforce that a better understanding of the events that occur after HI and TH in both males and females is necessary and would allow the development of more adequate and sex-specific therapeutic approaches.